Skip to content

Helicobacter pylori eradication from general practice: clinical benefits and health economics

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN57634776
Enrollment
Unknown
Registered
2004-01-23
Start date
1994-01-07
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive system diseases: Peptic ulcer disease Digestive System Peptic ulcer disease

Interventions

Treatment for H. pylori versus placebo

Sponsors

NHS R&D Regional Programme Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 50-59 years from selected General Practice (GP) surgeries (including asymptomatic volunteers as well as patients with dyspepsia)

Exclusion criteria

Exclusion criteria: 1. Severe mental illness 2. Severe medical illness that would make the subject unable to survive for two years 3. Allergy to proton inhibitors, clarythromycin or metronizadole 4. Unwillingness to abstain from alcohol whilst taking antibiotics 5. Pregnancy 6. Concomitant prescription of cisapride, warfarin, antihistamines or theophyllines

Design outcomes

Primary

MeasureTime frame
1. Absence of dyspepsia at two years 2. NHS dyspepsia costs for two years after the intervention

Secondary

MeasureTime frame
1. Dyspepsia subgroups 2. Quality of life 3. H. pylori eradication rates 4. Adverse events

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026